1. Strategies to produce virus-safe blood derivatives;Heimburger;Curr Stud Hematol Blood Transfus,1989
2. Measures to inactivate viral contaminants of pooled plasma products;Menache;Prog Clin Biol Res,1985
3. Robustness of solvent/detergent treatment of plasma derivatives: a data collection from Plasma Protein Therapeutics Association member companies;Dichtelmuller;Transfusion,2009
4. Enveloped virus inactivation by caprylate: a robust alternative to solvent-detergent treatment in plasma derived intermediates;Korneyeva;Biologicals,2002
5. Characterization and viral safety validation study of a pasteurized therapeutic concentrate of antithrombin III obtained through affinity chromatography;Biescas;Haematologica,1998